Uro-neurology: Phase III trials

A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Patients 5 to 18 Years of Age With Neurogenic Detrusor Overactivity

Solifenacin succinate

Phase III

Multiple worldwide locations

Recruiting

Click here for further information